Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Price-to-Operating-Cash-Flow : 12.49 (As of May. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing King-Friend Biochemical Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Nanjing King-Friend Biochemical Pharmaceutical Co's share price is ¥13.39. Nanjing King-Friend Biochemical Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.07. Hence, Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 12.49.

The historical rank and industry rank for Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:603707' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.98 Med: 32.9 Max: 224.08
Current: 12.49

During the past 11 years, Nanjing King-Friend Biochemical Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 224.08. The lowest was 10.98. And the median was 32.90.

SHSE:603707's Price-to-Operating-Cash-Flow is ranked better than
64.21% of 679 companies
in the Drug Manufacturers industry
Industry Median: 16.89 vs SHSE:603707: 12.49

Nanjing King-Friend Biochemical Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.07.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Nanjing King-Friend Biochemical Pharmaceutical Co was 278.80% per year.

During the past 11 years, Nanjing King-Friend Biochemical Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 104.90% per year. The lowest was -47.90% per year. And the median was -31.80% per year.

Nanjing King-Friend Biochemical Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing King-Friend Biochemical Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

73.59

49.29

14.62

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															57.60	30.20	18.26	14.62	10.46

Competitive Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Nanjing King-Friend Biochemical Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	13.39	/	1.072
	=	12.49

Nanjing King-Friend Biochemical Pharmaceutical Co's Share Price of today is ¥13.39.
Nanjing King-Friend Biochemical Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.07.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Nanjing King-Friend Biochemical Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nanjing King-Friend Biochemical Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061

Website

http://www.nkf-pharma.com

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.

Executives

Huang Xi Wei	Director
Liu Zu Qing	Supervisors
Xie Ju Hua	Director
Wu Gui Ping	senior management
Tang Yong Qun	Director
Qian Xiao Jie	senior management

Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Headlines

No Headlines